Lv5
1058 积分 2025-12-19 加入
Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis
12小时前
已完结
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma
12小时前
已完结
Multicenter Single-arm Phase II Trial of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma After Progression on First-line Atezolizumab Plus Bevacizumab
12小时前
已完结
FGF21 and the brain-liver axis: Harnessing sympathetic pathways in MASH
12小时前
已完结
Intestinal cGAS–STING–IFN signalling promotes obesity by downregulating microbiota-derived IAA in male mice
4天前
已完结
A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma
4天前
已完结
ERα–PADI4–CXCL8 Axis Drives MDSC‐Mediated Immune Evasion in Anaplastic Thyroid Carcinoma
4天前
已完结
Triglyceride glucose index as a causal risk factor for metabolic dysfunction-associated fatty liver disease: evidence from the National Health and Nutrition Examination Survey 2017-2020 and Mendelian randomization
18天前
已完结
Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis
19天前
已完结
Development and validation of a non-invasive score for at-risk metabolic dysfunction-associated steatohepatitis in individuals with obesity undergoing bariatric surgery
25天前
已完结
皖公网安备34019202002308
